Twist Bioscience (TWST) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 
Twist Bioscience Corporation  (NASDAQ: TWST)
 

Twist Bioscience Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the third quarter 2026, Twist Bioscience's inventory turnover ratio sequentially decreased to 6.62 in the third quarter 2026, otherwise the ratio remained above the average, as TWST's markets remain strong.Twist Bioscience's average inventory processing period in the Jun 30 2026 quarter, has increased to 55 days, from 54 days, in the Mar 31 2026 quarter.

Within Healthcare sector 56 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 404 in the second quarter 2026, to 577.

TWST Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Twist Bioscience Corporation Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TWST Inventory Turnover Ratio (Jun 30 2026)
III. Quarter		 (Mar 31 2026)
II. Quarter		 (Dec 31 2025)
I. Quarter		 (Sep 30 2025)
IV. Quarter		 (Jun 30 2025)
III. Quarter
Y / Y Inventory Growth 35.56 % 60.67 % 17.57 % 17.57 % -8.94 %
Y / Y Cost of Sales Growth 24.94 % 14.6 % 8.4 % 3.65 % -3.1 %
Inventory Turnover Ratio (TTM) 6.62 6.76 7.33 7.48 7.75
TWST's Total Ranking # 577 # 404 # 445 # 445 # 197
Average inventory processing period 55 54 50 49 47
Seq. Inventory Growth 4.91 % 18.39 % 0 % 9.14 % 24.34 %
Seq. Cost of Sales Growth 4.35 % 7.78 % 3.23 % 7.62 % -4.29 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 6
Healthcare Sector # 57
Overall Market # 577

Inventory Turnover Ratio Statistics
High Average Low
8.31 5.16 0.56
(Sep 30 2019)   (Dec 31 2018)



TWST Company Profile >> Back to TWST Efficiency Comparisons >> Compare TWST Inventory Turnover Ratio to its Competitors

Financial Statements
Twist Bioscience's Inventories $ 35 Millions Visit TWST's Balance sheet
Twist Bioscience's Cost of Revenues TTM $ 207 Millions Visit TWST's Income Statement
What are TWST's Sales? Visit TWST's Sales by Segment

Other Inventory Turnover Ratios
Twist Bioscience's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
TWST's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for TWST's Competitors
Inventory Turnover Ratio for TWST's Suppliers
Inventory Turnover Ratio for TWST's Customers

You may also want to know
TWST's Sales Growth Rates TWST's Pe Price to earnings ratio TWST's Receivables Turnover Ratio TWST's Stock Quote
TWST's Net Income Growth Rates TWST's Ps Price to Sales ratio TWST's Sales per Employee TWST's Asset Turnover Ratio
TWST's Net Margin TWST's Pb Price to Book ratio TWST's Financial Strength Ratios TWST's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Cryo cell International Inc   15.87 $ 6.869  Millions$ 0  Millions
Rosecliff Acquisition Corp I  14.94 $ 9.597  Millions$ 1  Millions
Catheter Precision Inc   14.83 $ 1.001  Millions$ 0  Millions
Agape Atp Corporation  14.52 $ 0.413  Millions$ 0  Millions
Earth Science Tech Inc   11.64 $ 8.974  Millions$ 1  Millions
Alnylam Pharmaceuticals Inc   11.45 $ 970.735  Millions$ 85  Millions
Infusystem Holdings Inc  10.92 $ 60.985  Millions$ 6  Millions
Irhythm Holdings Inc   10.79 $ 235.967  Millions$ 22  Millions
Genedx Holdings Corp   10.27 $ 140.202  Millions$ 14  Millions
Tarsus Pharmaceuticals Inc   10.20 $ 43.740  Millions$ 4  Millions
Lantheus Holdings Inc   10.09 $ 619.325  Millions$ 61  Millions
Sotera Health Company  10.04 $ 547.412  Millions$ 55  Millions
Edap Tms Sa  9.67 $ 62.351  Millions$ 6  Millions
Natera Inc   9.46 $ 672.186  Millions$ 71  Millions
Warby Parker Inc   9.27 $ 414.054  Millions$ 45  Millions
Hims and Hers Health Inc   9.23 $ 814.411  Millions$ 88  Millions
Polomar Health Services, Inc.  8.80 $ 1.233  Millions$ 0  Millions
Myriad Genetics Inc   8.31 $ 250.700  Millions$ 30  Millions
National Vision Holdings Inc   8.26 $ 841.416  Millions$ 102  Millions
Castle Biosciences Inc   8.14 $ 81.252  Millions$ 10  Millions
Autolus Therapeutics Plc  8.08 $ 99.009  Millions$ 12  Millions
The Oncology Institute Inc   8.03 $ 160.655  Millions$ 20  Millions
Nutriband Inc   7.92 $ 1.082  Millions$ 0  Millions
Novavax inc   7.61 $ 88.541  Millions$ 12  Millions
Inogen Inc   7.51 $ 196.617  Millions$ 26  Millions
Moderna Inc   7.50 $ 1,707.000  Millions$ 228  Millions
Cardiff Lexington Corporation  7.49 $ 4.042  Millions$ 1  Millions
Pulse Biosciences Inc   7.45 $ 1.182  Millions$ 0  Millions
Vanda Pharmaceuticals Inc   7.43 $ 13.506  Millions$ 2  Millions
Carlsmed Inc   7.42 $ 13.955  Millions$ 2  Millions

Date modified: 2026-09-13T23:42:31+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.